As an open access journal, Cancer Immunity’s collaborative network bridges tumor immunologists and the non-scientific community in the exchange of facts, ideas, and opinions, at no expense to the reader or author. In addition to the publication of original research articles, commentaries, reviews, and reflections, we offer our readers access to valuable resources and a variety of databases and analysis web tools that further strengthen scientific knowledge.
We encourage you to utilize the array of databases available:
- Peptide Database of T cell-defined tumor antigens of Benoit Van den Eynde, Pierre van der Bruggen, and colleagues
- SEREX Review, a repository of human tumor antigens defined by serological expression cloning updated by Yao-Tseng Chen
- Ludwig Institute for Cancer Research Tetramer Collection, aggregated by Immanuel Luescher and colleagues
- CT Gene Database, which provides information about gene structure, chromosomal mapping, proteins, immunoreactivity in cancer patients, and mRNA expression. The data has been incorporated in the CTDatabase, now accessible through LICR.
- Eight freely available databases including the Cancer Immunome Database, SYFPEITHI Database of MHC ligands and peptide motifs, and ESTDAB
- More than 30 different gene sequence analysis web tools in proteasomal cleavage, TAP binding, MHC-peptide binding, antigenic peptides, CTL epitopes, and tumor antigens
We also invite you to browse our vast repository of other resources such as current news and blogs, upcoming conferences and reports from previously held meetings; as well as general information on clinical trials, funding agencies, and cancer immunology societies and associations.